Prof Jeremy Chataway

Professor Jeremy Chataway is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, UCLH, and a Professor of Neurology at University College London. In May 2022 he was appointed as a Visiting Chair (Honorary Professor) at the University of Edinburgh.

After qualifying in medicine at Cambridge and Oxford Universities, and general medical training in London, he specialised in neurology with posts in Edinburgh, Cambridge, and London. He was awarded a PhD from Cambridge University in genetic epidemiology of multiple sclerosis.

Jeremy has been influential in shaping the evolution of clinical trial designs in neurodegenerative diseases through his leadership at UCL. He has helped develop robust methods for the selection of repurposed medicines for clinical trials.

As an Honorary Professor at Edinburgh, Jeremy helps to conceive, shape and support our clinical trials, including MND-SMART for motor neuron disease, and the UCL-led OCTOPUS for multiple sclerosis. Professor Chataway's well-deserved reputation amongst patient groups as an advocate of trials and champion of research participation for all people living with presently untreatable neurodegenerative conditions fits perfectly with the philosophy and ambitions of the Anne Rowling Clinic.